Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

tsxv:rx

POPULAR ARTICLES

BioSyent to Present at Planet MicroCap Las Vegas

pharmaceutical investing

BioSyent to Present at Planet MicroCap Las Vegas

BioSyent Declares Second Quarter 2026 Dividend

pharmaceutical investing

BioSyent Declares Second Quarter 2026 Dividend

BioSyent Releases Financial Results for First Quarter 2026

pharmaceutical investing

BioSyent Releases Financial Results for First Quarter 2026

LATEST ARTICLES

BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026

pharmaceutical investing

BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026

BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

pharmaceutical investing

BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

pharmaceutical investing

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

BioSyent Announces Grant of Restricted Share Units

pharmaceutical investing

BioSyent Announces Grant of Restricted Share Units

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

pharmaceutical investing

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

pharmaceutical investing

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

pharmaceutical investing

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

BioSyent to Acquire Oral Science Inc.

pharmaceutical investing

BioSyent to Acquire Oral Science Inc.

BioSyent Declares First Quarter 2026 Dividend

pharmaceutical investing

BioSyent Declares First Quarter 2026 Dividend

BioSyent Announces Renewal of Normal Course Issuer Bid

pharmaceutical investing

BioSyent Announces Renewal of Normal Course Issuer Bid

BioSyent Releases Financial Results for Q3 and YTD 2025

pharmaceutical investing

BioSyent Releases Financial Results for Q3 and YTD 2025

BioSyent Declares Fourth Quarter 2025 Dividend

pharmaceutical investing

BioSyent Declares Fourth Quarter 2025 Dividend

Latest News

Brixton Metals Launches Drilling Campaign at Langis Project

Bold Options Olcott Claims and Notes the Commencement of Ring of Fire Road Construction

Goldgroup Commences 24,000 M Diamond Drilling Program at San Francisco Gold Project

Steadright Announces Addition of a New Advisory Board Member, and Changes in Financial Year-End

SAGA Metals Highlights Radar Project's VTM Enriched Magnetic Concentrate up to 0.9% V2O5 Relative to Panzhihua, China Benchmark of 0.3% V2O5

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Premier American Uranium

Premier American Uranium (PUR:CC)

PUR:CC

VanadiumCorp Resource

VanadiumCorp Resource (VRB:CC)

VRB:CC

GoldInxs Mining

GoldInxs Mining (INXS:CC)

INXS:CC

Finlay Minerals

Finlay Minerals (FYL:CC)

FYL:CC

Coelacanth Energy

Coelacanth Energy (CEI:CC)

CEI:CC

Sankamap Metals

Sankamap Metals (SCU:CC)

SCU:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES